Member Info for dyl79

Lets hope that others may be interested as well?

The strange thing is that I sold some shares in BP and Shell to buy into 4d - if I would have stayed with them I would have made 25% increase in price and dividends of around 3-4%.

The lure of a greater return here caught my imagination - but I’m healthy and will learn. AIM pharmas is not for me going forward, too much risk and dilution involved. I think you need to play the game over a shorter period with AIM pharmas, rather than risk holding long term.

Back to the safer FTSE 100 me thinks.

The bottom line will be - whats the worth of the IP’s and is it likely to cause a bidding war?

After yesterday’s disappointing news I’ve had some tim to reflect on the situation, and hopefully learn going forwards.

The cash burn of £50-£70million per year is very high - in hindsight maybe too many fingers in different pies.

With a £30million mcap, it was going to be difficult to fund the next 12months - unless they curtailed or sold some of their IP’s. Maybe this is what OF saw.

Whilst a takeover or partnership may have been good - one hasn’t been forthcoming.

Even if the administrators can find a way to pay OF, or restructure the loan - the company would still need major changes to continue as a going concern as it cannot continue to spend what it has been doing.

It will be interesting to see if the administrators can sell the IP’s? How much? and to whom?

From my perspective I will not invest in a pharma again, too much of a risk in the development stage where they mostly do not bring in any income and spend tends to be very high. Thus causing share dilutions.

There must be some good value to the IP - surely enough to pay off everyone and give the shareholders some return.

Surely 4d must have some cash in the bank.

So it looks like two things to me;

1) The BoD can save it out of administration

2) The assets are sold, if there is a buyer, and that money is used to pay off OF and other debtors. Depending on the total asset value, we may see something back. The question is, how much are the assets are worth in the current market.

That would raise so many questions / legal challenges though?

I’m guessing they just lost confidence in the BoD and decided they wanted their money back.

If there are buyers - how much is the company’s assets worth…..

We may get something back depending on what can be sold and after debt payments.

Sorry to hear that ctrl123, lets hope they can salvage the company somehow.

Its a case if the BoD can raise the £14million or come to some arrangement with OF - depends then how much further funding they require going forward.

If the price was walked diwn by the BoD for a lowball takeover offer - say 25p - surely the BoD would have even more uncomfortable quesions than in their last disasterous presentation.

Trying to be positive but seen something similar with Flybe when the Bod screwed over the shareholders.

Wonder if we get to know today - or they make us wait until Monday!

My concern is a lowball takeover offer, which may be preferable to the BoD than a 150% or so share dilution. With the BoD staying on in the new company?

I remember the fiasco with Flybe and Virgin - got caught out a bit.

Lets hope this is better news.

I’m also still in, averaging 58p so currently.down around 75%.

Not a big investment from me and no point selling at current prices. - so will sit it out. But won’t be investing anymore until the BoD does something positive.

I think we are all (except the shorters) are looking for the BoD to steady the ship. Post some timelines / reasurrances.

This is where they are failing imo - they don’t seem to be doing their homework and anticipating what we as shareholders are looking for. Hence the further reduction in the sp.

Got to say it’s dissappointing to see the share price where it is, especially when it hit £1.50 on NASDAQ news. a year or so ago.

Fundamentals are still in place but I’m unsure of the BoD and if they are the right people to take the company forwards.

We need some sort of future plan from the BoD to give any potential investors some confidence in the share - otherwise the market/shorters will just take it down even further based on the premises of requiring additional funding.

My average is around 58p but I won’t invest anymore until I see something better from the BoD.

Yeah it’s a difficult time at the minute if you hold DDDD, it’s come down from circa. 120p last year.

I got in around 58p so am sitting at a 50% loss.

I personally wouldn’t invest in shares at the moment, especially this one. as its high risk. Constant seller, shorters, Putin and inflation in general.

Data may well come good - I think it will be ok but that’s just my opinion.

I’m sitting on too much of a loss to sell anyway - happy to hold and see what happens.

I’m not sure what % of shares SO originally had but it seems strange that someone who had say 10% of the shares can cause the value to drop so much upon selling.

I note that the general pharma market has taken quite a tumble this year - so maybe the reason is a bit of SO selling and general market consensus.

As stated before I got in at 58p which I thought was low - but I got that one wrong.

There just hasn’t been any bad results to justify the decrease imo - ok maybe a lack of information from DDDD doesn’t help - but as per my previous post I’m in it until it comes good, or goes bust. Not selling at these low prices.